Can You Get TRT Online in Minnesota? The Rules in 2026
Can You Get TRT Online in Minnesota? What the Rules Actually Say
Short answer: yes, currently. Longer answer: the rule that makes it possible is temporary, it has been extended four times, and the current extension runs out on December 31, 2026.
If you are on testosterone therapy through a telehealth provider in Minnesota, or thinking about starting, this is worth understanding rather than discovering in January.
Disclosure first: Slym Wellness has no clinic in Minnesota. Our providers are Minnesota-licensed and all visits are virtual, with labs drawn at a site near you.
Why testosterone is different from other prescriptions
Testosterone is a Schedule III controlled substance under federal law. That puts it in a different category from most of what telehealth handles.
Under the Ryan Haight Act of 2008, a provider generally must conduct an in-person medical evaluation before prescribing a controlled substance. That law predates modern telehealth and would, on its own, make online TRT impossible without an initial office visit.
What has made it possible since March 2020 is a set of temporary exceptions, usually called the telemedicine flexibilities.
What the current rule allows
On December 31, 2025, the DEA and HHS issued a fourth temporary extension of those flexibilities, running through December 31, 2026.
Under it, a DEA-registered practitioner may prescribe Schedule II through V controlled substances by telemedicine without a prior in-person medical evaluation, provided the encounter and prescription meet the rule’s conditions. For most controlled substances, including testosterone, the visit must be a real-time, two-way audio-video encounter. A phone call does not qualify.
The flexibilities apply to all practitioner-patient relationships, not only those established during the public health emergency.
What happens after December 31, 2026
This is the part nobody can answer with certainty, and anyone claiming otherwise is guessing.
The DEA has proposed a permanent framework built around special registrations for telehealth prescribers. That proposal was published in January 2025 and has not been finalized. A final rule was submitted for review in August 2026 and remains under review as of this writing.
Three possibilities: the DEA finalizes the permanent rule before the deadline, issues a fifth extension, or the flexibilities lapse. The agencies have described each previous extension as a bridge while they finish the permanent rule.
What this means for you practically. If you are on TRT through a telehealth provider, ask your clinic now what its plan is. A clinic that has thought about this will have an answer: how patients get notified, what the bridge plan looks like, and whether an in-person evaluation will become necessary. A clinic that has not thought about it is telling you something.
Minnesota’s own rules on top of the federal ones
Federal permission is not sufficient on its own. State rules apply as well, and Minnesota has specific ones.
The visit must be real-time audio and video. Minnesota law defines telehealth as delivery of care through real-time, two-way interactive audio and visual communication. Email, text messaging and fax are explicitly excluded and cannot be the basis for a new prescription. An intake questionnaire followed by a prescription is not a Minnesota telehealth visit.
Your provider must be licensed here. A provider treating a patient located in Minnesota must hold a Minnesota license, or register with the Minnesota Board of Medical Practice under its telemedicine registration pathway, which requires an unrestricted license in their home state, no Minnesota office, no in-person meetings with patients in Minnesota, and annual renewal.
Where you are located is what matters, not where the clinic is. If you are physically in Minnesota during the visit, Minnesota rules govern it.
What a lapse would actually look like
Worth thinking through now rather than in January, because the practical consequences are not dramatic but they are inconvenient.
If the flexibilities expire without a replacement, the Ryan Haight requirement returns: a provider generally needs an in-person medical evaluation before prescribing a controlled substance. That does not make your prescription disappear retroactively, and it does not make telehealth illegal. It affects whether a new or continuing controlled-substance prescription can be issued to a patient the prescriber has never examined in person.
Most likely outcomes for someone already established on therapy: a clinic arranges an in-person evaluation through a local partner, a patient transitions to a local prescriber for the controlled portion while keeping virtual care for everything else, or the agencies issue another extension and nothing changes.
What you can do now. Make sure you are not running your prescription down to the last few days in late December. Ask your clinic for its plan in writing. And if you have been putting off getting evaluated, doing it before the deadline keeps more options open than doing it after.
None of this is a reason for alarm. It is a reason to ask one question of your provider in the next few weeks.
The diagnostic standard has not changed
None of the above changes what a legitimate diagnosis requires. Per the AUA guideline, low testosterone requires symptoms plus two total testosterone measurements below 300 ng/dL, from separate early-morning blood draws.
A telehealth clinic that prescribes from one afternoon lab, or from a questionnaire alone, is not meeting that standard regardless of what federal rule is in effect.
Questions about your treatment plan? Call 904-788-3747 or see our men’s hormone therapy program.
Why this does not apply to everything Slym treats
Worth separating, because the deadline gets discussed as though it affects all telehealth and it does not.
Testosterone is a controlled substance. Most of what telehealth handles is not. Thyroid medication, blood pressure medication, most women’s hormone therapy, and the majority of everyday prescriptions sit entirely outside the controlled-substance framework, and nothing about December 31 touches them.
Women’s hormone therapy is the clearest contrast. Estrogen and progestogen are not controlled substances, so that care runs on ordinary telehealth rules with no federal deadline attached.
Weight loss medication depends on what is prescribed. GLP-1 medications are not controlled substances. Certain older appetite suppressants are, and those would be affected.
So if you are a Minnesota patient of a virtual clinic and wondering whether this applies to you, the question is narrow: am I being prescribed a controlled substance? For most people the answer is no.
Five questions worth asking your telehealth clinic right now
- Is my provider licensed in Minnesota, or registered under the telemedicine pathway?
- Are my visits conducted by real-time audio and video?
- Did you require two separate early-morning testosterone draws before diagnosing me?
- What is your plan if the federal telemedicine flexibilities change after December 31, 2026?
- How will you notify me if my care has to change?
Where we serve
Minnesota-licensed providers, entirely virtual: Minneapolis, St. Paul, Edina, Eden Prairie, Minnetonka, Wayzata, Maple Grove, Plymouth, Woodbury, Stillwater, Bloomington, Eagan, Burnsville and statewide.
This article is general information, not medical or legal advice. Federal telemedicine rules are actively changing. Verify current status before relying on any pathway.
Sources
- Federal Register. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications. December 31, 2025.
- U.S. Department of Health and Human Services. Prescribing controlled substances via telehealth.
- American Urological Association. Evaluation and Management of Testosterone Deficiency: AUA Guideline.
Frequently Asked Questions
Can I legally get testosterone prescribed online in Minnesota?
Currently yes. Testosterone is a Schedule III controlled substance, and a federal temporary rule allows DEA-registered practitioners to prescribe Schedule II through V controlled substances by telemedicine without a prior in-person evaluation through December 31, 2026.
What happens after December 31, 2026?
It is not yet settled. The DEA has a permanent rule under review and has issued four temporary extensions so far. Ask your clinic what its plan is rather than assuming nothing will change.
Does the visit have to be video, or can it be a phone call?
For most controlled substances including testosterone, the encounter must be real-time, two-way audio-video. Minnesota also defines telehealth as requiring real-time audio and visual communication, and excludes email, text and fax.
Can a clinic prescribe TRT from a questionnaire?
Not lawfully in Minnesota. State law requires a real-time audio-visual encounter, and text or form-based intake alone does not establish a valid basis for a new prescription.
Does my provider have to be licensed in Minnesota?
A provider treating a patient located in Minnesota must hold a Minnesota license or be registered under the state’s telemedicine registration pathway. Where you are located during the visit is what determines which state’s rules apply.
Do I still need blood work if everything is virtual?
Yes, and more of it than people expect. Diagnosis requires symptoms plus two total testosterone measurements below 300 ng/dL from separate early-morning draws. Labs are drawn at a site near you.
Is online TRT less thorough than in-person?
It does not have to be. Low testosterone is diagnosed through blood work and symptom history rather than physical examination. What matters is whether the clinic follows the diagnostic standard, not whether the visit is virtual.
What should I ask my current clinic?
Whether your provider is Minnesota-licensed, whether visits are audio-video, whether two morning draws were required before diagnosis, and what the plan is if the federal rules change after December 31.
